Reducing Residual Risk for Patients on Statin Therapy: The Potential Role of Combination Therapy

This publication has 30 references indexed in Scilit:

• Results of the National Cholesterol Education (NCEP) Program Evaluation Project Utilizing Novel E-Technology (NEPTUNE) II Survey and Implications for Treatment Under the Recent NCEP Writing Group Recommendations
  The American Journal of Cardiology, 2005
• Clinical Significance of Statin Pleiotropic Effects
  Circulation, 2005
• Effectiveness and tolerability of simvastatin plus fenofibrate for combined hyperlipidemia (the SAFARI trial)
  The American Journal of Cardiology, 2005
• Reporting rate of rhabdomyolysis with fenofibrate + statin versus gemfibrozil + any statin
  The American Journal of Cardiology, 2005
• Risk of adverse events with fibrates
  The American Journal of Cardiology, 2004
• Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study
  The Lancet, 2004
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
  Published by Elsevier ,2002
• Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
  JAMA, 2001
• Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels
  New England Journal of Medicine, 1998
• Baseline characteristics in the Cholesterol and Recurrent Events (CARE) trial of secondary prevention in patients with average serum cholesterol levels
  The American Journal of Cardiology, 1995